AstraZeneca said on Tuesday that it has submitted a request for emergency use authorization of an antibody drug designed to help prevent symptomatic COVID-19.The antibody therapy, called AZD7442, provides “significant reduction” in the…
Copyright © 2024 | WordPress Theme by MH Themes